[Discussion on role of enterprises in re-evaluation of traditional Chinese medicine injection].
By analyzing several aspects of the problem of traditional Chinese medicine injection on basic research, quality standards, production technology and clinical application, put forward content and steps of re-evaluation of traditional Chinese medicine injection.
Li
Xinling
X
Center for Drug Reevaluation, State Food and Drug Administration, Beijing 100045, China. lixinling@cdr.gov.cn
Song
Ligang
L
Liu
Ying
Y
Bo
Yanjun
Y
D035843:Biomedical Research; D004341:Drug Evaluation; D064420:Drug-Related Side Effects and Adverse Reactions; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D006801:Humans; D008137:Longitudinal Studies; D008516:Medicine, Chinese Traditional / Q000191:economics* / Q000379:methods; D017150:Public Sector; D012107:Research Design
D004365:Drugs, Chinese Herbal